{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:55:54Z","timestamp":1795085754513,"version":"4.10.2"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>With an estimated 25% of the global population infected with<jats:italic>Mycobacterium tuberculosis<\/jats:italic>(<jats:italic>Mtb<\/jats:italic>), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatment is largely uncharacterized, and antibody profiling could provide insights into disease resolution. Here we focused on the distinctive TB-specific serum antibody features in active TB disease (ATB) and compared them with latent TB infection (LTBI) or treated ATB (txATB). As expected, di-galactosylated glycan structures (lacking sialic acid) found on IgG-Fc differentiated LTBI from ATB, but also discriminated txATB from ATB. Moreover, TB-specific IgG4 emerged as a novel antibody feature that correlated with active disease, elevated in ATB, but significantly diminished after therapy. These findings highlight 2 novel TB-specific antibody changes that track with the resolution of TB and may provide key insights to guide TB therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2021.679973","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T07:30:06Z","timestamp":1625470206000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Antibody Subclass and Glycosylation Shift Following Effective TB Treatment"],"prefix":"10.3389","volume":"12","author":[{"given":"Patricia S.","family":"Grace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Dolatshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenette L.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Petrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H. M.","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Lauffenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines Against Tuberculosis: Where Are We and Where do We Need to Go","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PloS Pathog"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological Benefits of More-Effective Tuberculosis Vaccines, Drugs, and Diagnostic","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci - PNAS"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0797","article-title":"Systematic Screening for Active Tuberculosis: Rationale, Definitions and Key Considerations [State of the Art Series. Active Case Finding\/Screening. Number 1 in the Series]","volume":"17","author":"L\u00f6nnroth","year":"2013","journal-title":"Int J Tuberculosis Lung Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902129","article-title":"Community-Wide Screening for Tuberculosis in a High-Prevalence Setting","volume":"381","author":"Marks","year":"2019","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00214014","article-title":"Towards Tuberculosis Elimination: An Action Framework for Low-Incidence Countries","volume":"45","author":"Lonnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma Interferon Release Assays for Detection of Mycobacterium Tuberculosis Infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-1377-8","article-title":"Sensitivity of a New Commercial Enzyme-Linked Immunospot Assay (T SPOT-TB) for Diagnosis of Tuberculosis in Clinical Practice","volume":"24","author":"Meier","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0439-x","article-title":"A Multi-Cohort Study of the Immune Factors Associated With M. Tuberculosis Infection Outcomes","volume":"560","author":"Chowdhury","year":"2018","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature09247","article-title":"An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005687","article-title":"Patients With Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes Following Successful Treatment","volume":"12","author":"Joosten","year":"2016","journal-title":"PloS Pathog"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00028507","article-title":"Quantitative Scoring of an Interferon-Gamma Assay for Differentiating Active From Latent Tuberculosis","volume":"30","author":"Janssens","year":"2007","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit265","article-title":"T-Cell Immunophenotyping Distinguishes Active From Latent Tuberculosis","volume":"208","author":"Pollock","year":"2013","journal-title":"J Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-\u03b1+ Mycobacterium Tuberculosis\u2013Specific CD4+ T Cell Responses Discriminate Between Latent Infection and Active Disease","volume":"17","author":"Harari","year":"2011","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13272","article-title":"Update on Tuberculosis Biomarkers: From Correlates of Risk, to Correlates of Active Disease and of Cure From Disease","volume":"23","author":"Goletti","year":"2018","journal-title":"Respirology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI77990","article-title":"Biomarkers on Patient T Cells Diagnose Active Tuberculosis and Monitor Treatment Response","volume":"125","author":"Adekambi","year":"2015","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01089-2018","article-title":"Can We Predict Tuberculosis Cure? What Tools Are Available","volume":"52","author":"Goletti","year":"2018","journal-title":"Eur Respir J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12269","article-title":"The Human Immune Response to Tuberculosis and Its Treatment: A View From the Blood","volume":"264","author":"Cliff","year":"2015","journal-title":"Immunol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","article-title":"Signaling by Antibodies: Recent Progress","volume":"35","author":"Bournazos","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.3.387-398.2005","article-title":"Comparison of Antibody Repertoires Against Staphylococcus Aureus in Healthy Individuals and in Acutely Infected Patient","volume":"12","author":"Dryla","year":"2005","journal-title":"Clin Vaccine Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2015.06.018","article-title":"Specific Serum IgG at Diagnosis of Staphylococcus Aureus Bloodstream Invasion Is Correlated With Disease Progression","volume":"128","author":"Stentzel","year":"2015","journal-title":"J Proteomics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01007-14","article-title":"Isotype Switching Increases Efficacy of Antibody Protection Against Staphylococcal Enterotoxin B-Induced Lethal Shock and Staphylococcus Aureus Sepsis in Mice","volume":"5","author":"Varshney","year":"2014","journal-title":"mBio"},{"key":"B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/srep28207","article-title":"IgG1 Fc N-Glycan Galactosylation as a Biomarker for Immune Activation","volume":"6","author":"de Jong","year":"2016","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1513456112","article-title":"A Common Glycan Structure on Immunoglobulin G for Enhancement of Effector Functions","volume":"112","author":"Lin","year":"2015","journal-title":"Proc Natl Acad Sci - PNAS"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65708","article-title":"Natural Variation in Fc Glycosylation of HIV-Specific Antibodies Impacts Antiviral Activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu388","article-title":"Aberrant Serum Immunoglobulin G Glycosylation in Chronic Hepatitis B Is Associated With Histological Liver Damage and Reversible by Antiviral Therapy","volume":"211","author":"Ho","year":"2014","journal-title":"J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/srep28098","article-title":"Glycosylation of Plasma IgG in Colorectal Cancer Prognosis","volume":"6","author":"Theodoratou","year":"2016","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.83","article-title":"Distribution of IgG Galactosylation as a Promising Biomarker for Cancer Screening in Multiple Cancer Types","volume":"26","author":"Ren","year":"2016","journal-title":"Cell Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.06.010","article-title":"Clinical Usefulness of Serum Antibodies as Biomarkers of Gastrointestinal and Liver Diseases","volume":"49","author":"Di Sabatino","year":"2017","journal-title":"Digestive liver Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-Citrullinated Protein Antibodies Acquire a Pro-Inflammatory Fc Glycosylation Phenotype Prior to the Onset of Rheumatoid Arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1073\/pnas.1111413109","article-title":"Identification of a Common Immune Signature in Murine and Human Systemic Salmonellosis","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"B32","article-title":"Heterogeneity of Antibody Response to Myobacterial Antigens in Different Clinical Manifestations of Pulmonary Tuberculosis","author":"Demkow","year":"2007","journal-title":"J Physiol Pharmacol an Off J Polish Physiol Soc"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2018.01.007","article-title":"Evaluation of Mycobacterium Tuberculosis-Specific Antibody Responses for the Discrimination of Active and Latent Tuberculosis Infection","volume":"70","author":"Wang","year":"2018","journal-title":"Int J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.8.3936-3940.1998","article-title":"Heterogeneous Antibody Responses in Tuberculosis","volume":"66","author":"Lyashchenko","year":"1998","journal-title":"Infect Immun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody Glycosylation in Inflammation, Disease and Vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A Functional Role for Antibodies in Tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz643","article-title":"Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosi","volume":"64","author":"Lu","year":"2020","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and Uninfected Healthcare Workers Exposed to TB Make Protective Antibodies Against Mycobacterium Tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1172\/JCI128459","article-title":"Capsular Glycan Recognition Provides Antibody-Mediated Immunity Against Tuberculosis","volume":"2015","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606330","article-title":"Human Isotype-Dependent Inhibitory Antibody Responses Against Mycobacterium Tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of Innate and Cell-Mediated Immunity by Antimycobacterial Antibodies","volume":"73","author":"de Valliere","year":"2005","journal-title":"Infect Immun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.9.6101-6109.2005","article-title":"Therapeutic Efficacy of High-Dose Intravenous Immunoglobulin in Mycobacterium Tuberculosis Infection in Mice","volume":"73","author":"Roy","year":"2005","journal-title":"Infect Immun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tube.2015.11.001","article-title":"Detection of IgG1 Antibodies Against Mycobacterium Tuberculosis DosR and Rpf Antigens in Tuberculosis Patients Before and After Chemotherapy","volume":"96","author":"Mattos","year":"2016","journal-title":"Tuberculosis (Edinburgh Scotland)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.10.4.702-709.2003","article-title":"Changes in Avidity and Level of Immunoglobulin G Antibodies to Mycobacterium Tuberculosis in Sera of Patients Undergoing Treatment for Pulmonary Tuberculosis","volume":"10","author":"Arias-Bouda","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting Polyclonal Vaccine-Induced Humoral Immunity Against HIV Using Systems Serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell (Cambridge)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1800098","DOI":"10.1183\/13993003.00098-2018","article-title":"The World Health Organization Standards for Tuberculosis Care and Management","volume":"51","author":"Gilpin","year":"2018","journal-title":"Eur Respir J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The Lasso Method for Variable Selection in the Cox Model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0161-0","article-title":"Route of Immunization Defines Multiple Mechanisms of Vaccine-Mediated Protection Against SIV","volume":"24","author":"Ackerman","year":"2018","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/mi.2015.51","article-title":"Increased Levels of Inflammatory Cytokines in the Female Reproductive Tract Are Associated With Altered Expression of Proteases, Mucosal Barrier Proteins, and an Influx of HIV-Susceptible Target Cells","volume":"9","author":"Arnold","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001338","article-title":"In Vivo Systems Analysis Identifies Spatial and Temporal Aspects of the Modulation of TNF-\u03b1-Induced Apoptosis and Proliferation by MAPK","volume":"4","author":"Lau","year":"2011","journal-title":"Sci Signaling"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemolab.2004.12.011","article-title":"Performance of Some Variable Selection Methods When Multicollinearity Is Present","volume":"78","author":"Chong","year":"2005","journal-title":"Chemom Intell Lab Syst"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1159\/000196563","article-title":"IgA Immune Response Against the Mycobacterial Antigen A60 in Patients With Active Pulmonary Tuberculosis","volume":"63","author":"Alifano","year":"1996","journal-title":"Respiration Int Rev Thorac Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190989","article-title":"IgA and IgG Against Mycobacterium Tuberculosis Rv2031 Discriminate Between Pulmonary Tuberculosis Patients, Mycobacterium Tuberculosis-Infected and non-Infected Individuals","volume":"13","author":"Abebe","year":"2018","journal-title":"PloS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1074\/mcp.RA118.001185","article-title":"Multi-Isotype Glycoproteomic Characterization of Serum Antibody Heavy Chains Reveals Isotype- and Subclass-Specific N-Glycosylation Profiles","volume":"18","author":"Chandler","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0196163","DOI":"10.1371\/journal.pone.0196163","article-title":"Changes in N-Glycans of IgG4 and Its Relationship With the Existence of Hypocomplementemia and Individual Organ Involvement in Patients With IgG4-Related Disease","volume":"13","author":"Konno","year":"2018","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"228ra238","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Trans Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65579","article-title":"IgG4 Subclass Antibodies Impair Antitumor Immunity in Melanoma","volume":"123","author":"Karagiannis","year":"2013","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(01)00025-6","article-title":"Role of Natural and Immune IgM Antibodies in Immune Responses","volume":"37","author":"Boes","year":"2000","journal-title":"Mol Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-\u03b3-Independent Immune Markers of Mycobacterium Tuberculosis Exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.01.033","article-title":"Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis","volume":"17","author":"Kemna","year":"2017","journal-title":"EBioMedicine"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1021\/pr400589m","article-title":"Association Between Galactosylation of Immunoglobulin G and Improvement of Rheumatoid Arthritis During Pregnancy Is Independent of Sialylation","volume":"12","author":"Bondt","year":"2013","journal-title":"J Proteome Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0450-1","article-title":"Pro-Inflammatory Pattern of IgG1 Fc Glycosylation in Multiple Sclerosis Cerebrospinal Fluid","volume":"12","author":"Wuhrer","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/CVI.05550-11","article-title":"Comparative Evaluation of Profiles of Antibodies to Mycobacterial Capsular Polysaccharides in Tuberculosis Patients and Controls Stratified by HIV Status","volume":"19","author":"Yu","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00104-20","article-title":"HIV Is Associated With Modified Humoral Immune Responses in the Setting of HIV\/TB Coinfection","volume":"5","author":"van Woudenbergh","year":"2020","journal-title":"mSphere"},{"key":"B66","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.148.9.2731","article-title":"Control of Allergic Reactivity in Human Filariasis. Predominant Localization of Blocking Antibody to the IgG4 Subclass","volume":"148","author":"Hussain","year":"1992","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1567","article-title":"Differential Decline in Filaria-Specific IgG1, IgG4, and IgE Antibodies in Brugia Malayi-Infected Patients After Diethylcarbamazine Chemotherapy","volume":"172","author":"Atmadja","year":"1995","journal-title":"J Infect Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1128\/IAI.02286-14","article-title":"IgG4 Subclass-Specific Responses to Staphylococcus Aureus Antigens Shed New Light on Host-Pathogen Interaction","volume":"83","author":"Swierstra","year":"2015","journal-title":"Infect Immun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.105","article-title":"An Elevated IgG4 Response in Chronic Infectious Aortitis Is Associated With Aortic Atherosclerosis","volume":"28","author":"Siddiquee","year":"2015","journal-title":"Modern Pathol"},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic Aspects of IgG4 Antibodies. I. Prolonged Immunization Results in an IgG4-Restricted Response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jaci.2008.01.072","article-title":"Grass Pollen Immunotherapy: IL-10 Induction and Suppression of Late Responses Precedes IgG4 Inhibitory Antibody Activity","volume":"121","author":"Francis","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-019-06451-2","article-title":"IgG4 Antibodies From Patients With Asymptomatic Bancroftian Filariasis Inhibit the Binding of IgG1 and IgG2 to C1q in a Fc-Fc-Dependent Mechanism","volume":"118","author":"Prodjinotho","year":"2019","journal-title":"Parasitol Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.44Immunology","article-title":"Human Immunoglobulin Classes and Subclasses Show Variability in VDJ Gene Mutation Levelshuman Immunoglobulin Classes and Subclasses Show Variability in VDJ Gene Mutation Levels","volume":"92","author":"Jackson","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-015-0580-7","article-title":"IgG4 Characteristics and Functions in Cancer Immunity","volume":"16","author":"Crescioli","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.13227","article-title":"An Epidemic of Tuberculosis With a High Rate of Tuberculin Anergy Among a Population Previously Unexposed to Tuberculosis, the Yanomami Indians of the Brazilian Amazo","volume":"94","author":"Sousa","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16401","article-title":"Detection of a Combination of Serum IgG and IgA Antibodies Against Selected Mycobacterial Targets Provides Promising Diagnostic Signatures for Active TB","volume":"8","author":"Awoniyi","year":"2017","journal-title":"Oncotarget"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.11.5.942-951.2004","article-title":"Epitope-Specific Antibody Levels Demonstrate Recognition of New Epitopes and Changes in Titer But Not Affinity During Treatment of Tuberculosis","volume":"11","author":"Bothamley","year":"2004","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.679973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T20:25:29Z","timestamp":1672691129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.679973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2021.679973"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.679973","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2021.679973.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"article-number":"679973"}}